Areteia Therapeutics
5 clinical trials · Sponsor
| Record | Firm | Date |
|---|---|---|
| A Study to Assess the Effects of Dexpramipexole in Participants With Eosinophilic COPD (NCT06533553) | Areteia Therapeutics | 2024-07-09 |
| Phase III Long-Term Extension Study With Dexpramipexole (NCT06388889) | Areteia Therapeutics | 2024-06-12 |
| A Study to Assess the Effect of Dexpramipexole in Adolescents and Adults With Severe Eosinophilic Asthma (EXHALE-3) (NCT05813288) | Areteia Therapeutics | 2023-03-27 |
| A Study to Assess the Effect of Dexpramipexole in Adolescents and Adults With Severe Eosinophilic Asthma. (NCT05763121) | Areteia Therapeutics | 2023-01-30 |
| A Study to Assess the Effect of Dexpramipexole in Adolescents and Adults With Eosinophilic Asthma (NCT05748600) | Areteia Therapeutics | 2023-01-30 |
Track Areteia Therapeutics automatically
Every clearance here is in the API, with alerts when new ones post.